As ‘FS’ endorsed prescription items become more common, Community Pharmacy England has released updated guidance on how pharmacies should handle these prescriptions. Community pharmacies are seeing an increase in electronic prescriptions with items endorsed ‘FS’ for free supply of sexual health treatment. This increase has been partially driven by the adoption of EPS by sexual
Read moreMHRA Class 4 Medicines Defect Information: Entyvio 108mg solution for injection in pre-filled syringe (Takeda UK Limited) Drug alert number: EL (24)A/55 Date issued: 18 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Entyvio 108mg solution for injection in pre-filled syringe Company name:
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (15/11/2024) announced the following initial list of price concessions for November 2024: Drug Pack size Price concession Apixaban 2.5mg tablets 60 £4.20 Cefalexin 500mg capsules 21 £2.67 Chloramphenicol
Read moreCommunity Pharmacy England’s in-house Drug Tariff and funding experts have created a new video providing guidance on how to correctly endorse and claim for any supplies made against a Serious Shortage Protocol (SSP). This is part of Community Pharmacy England’s ‘Funding & Reimbursement Shorts’ series, which has been created to provide pharmacy owners and their
Read moreThe Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Monomax® XL 60mg tablets is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP074 Monomax® XL 60mg tablets expires at 23.59pm on Friday 15 November 2024. After this date, any prescriptions for Monomax® XL 60mg tablets
Read moreAre you passionate about community pharmacy services? If so, we may have the perfect job opportunity for you! We are seeking a new recruit to join our Services Team to support the development of community pharmacy services, with a particular focus on locally commissioned services. There will be plenty of interesting work to do as
Read moreSince the Autumn Budget, Community Pharmacy England has been working to ensure that the impact of the announced changes on community pharmacies is fully understood by Government, and to argue once again that community pharmacies urgently need a funding uplift. Chief Executive Janet Morrison met with Minister for Care Stephen Kinnock on the day of
Read more20 parliamentarians have signed a letter to the Secretary of State for Health and Social Care, Wes Streeting MP, calling for urgent government action to safeguard the future of community pharmacies. Supported by Community Pharmacy England, the cross-party letter describes the financial challenges facing the sector and calls on the Department of Health and Social
Read moreThe deadline to register interest in participating in an important fiscal review of the community pharmacy sector has been extended to Monday 18th November. With pharmacies across the country struggling to cope under intolerable financial pressures, NHS England’s independent economic review offers an opportunity to demonstrate how much it actually costs to run a pharmacy
Read moreMHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd) Drug alert number: EL (24)A/54 Date issued: 12 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Omeprazole 40mg Powder for solution for infusion. Company name: Viatris
Read more
